⌘K

Login Start Free

Home/Filings/4/0000950170-24-038104

4//SEC Filing

FLAVIN JOHN L 4

Accession 0000950170-24-038104

CIK 0001782223other

View on SEC.gov Company Profile

Filed

Mar 27, 8:00 PM ET

Accepted

Mar 28, 4:33 PM ET

Size

4.7 KB

Accession

0000950170-24-038104

Insider Transaction Report

Form 4

Period: 2024-03-26

Pyxis Oncology, Inc.PYXS

Director

Transactions

Award
Common Stock
2024-03-26+35,219→ 413,015 total

Footnotes (1)

[F1]Represents restricted stock units that vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Pyxis Oncology, Inc.

CIK 0001782223

Entity typeother

Related Parties

1

filerCIK 0001126556

Filing Metadata

Form type: 4
Filed: Mar 27, 8:00 PM ET
Accepted: Mar 28, 4:33 PM ET
Size: 4.7 KB

View on SEC.gov